首页> 外文期刊>American Journal of Physiology >Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.
【24h】

Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.

机译:心力衰竭患者对多巴酚丁胺的正性肌力反应的氧化还原调节受到损害。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

It has been suggested that oxidative stress contributes to impaired left ventricular (LV) contractility in the setting of heart failure (HF). To test this hypothesis, we studied the effect of an antioxidant on contractility at rest and in response to dobutamine in 10 HF patients. We hypothesized that vitamin C would augment contractility in HF and that this effect would be of a greater magnitude in HF patients compared with patients with normal LV (NLV) function. Data from 10 patients with NLV function who participated in this study are included in this report and have been published elsewhere. A micromanometer-tipped catheter was introduced into the LV. In the experimental protocol, an infusion catheter was positioned in the left main coronary artery. The peak positive rate of change of LV pressure (LV +dP/dt) was measured in response to the intravenous infusion of dobutamine before and during the intracoronary infusion of vitamin C (96 mg/min). Vitamin C had no effect on basal LV +dP/dt in either HF or NLV groups. The infusion of vitamin C augmented the LV +dP/dt response to dobutamine by 22 +/- 4% in the NLV function group. In contrast, vitamin C had no effect on the inotropic response to dobutamine in the HF group. In the control protocol, without vitamin C, no differences were observed between responses to two sequential dobutamine infusions in either group (HF, n = 11; NLV, n = 9). Therefore, a positive effect of vitamin C on contractility was limited to patients with NLV function. The absence of this effect in HF patients may suggest that normal redox responsiveness is lost in this disease state.
机译:有人提出,在心力衰竭(HF)的情况下,氧化应激会导致左心室(LV)收缩力受损。为了验证该假设,我们研究了10名HF患者中抗氧化剂对静息收缩力和多巴酚丁胺反应的影响。我们假设维生素C会增加HF的收缩力,并且与LV(NLV)功能正常的患者相比,HF患者的这种影响更大。参与本研究的10名具有NLV功能的患者的数据已包括在本报告中,并已在其他地方发表。将微压力计尖端的导管引入LV。在实验方案中,将输液导管放置在左主冠状动脉中。在冠状动脉内注入维生素C之前和期间,应多巴酚丁胺的静脉输注(96 mg / min),测量左室压力的峰值正变化率(LV + dP / dt)。 HF或NLV组的维生素C对基础LV + dP / dt无影响。在NLV功能组中,输注维生素C使对多巴酚丁胺的LV + dP / dt反应增强了22 +/- 4%。相反,在HF组,维生素C对正丁多巴胺的肌力反应没有影响。在没有维生素C的对照方案中,两组中连续两次多巴酚丁胺输注的反应之间均未观察到差异(HF,n = 11; NLV,n = 9)。因此,维生素C对收缩性的积极作用仅限于具有NLV功能的患者。在HF患者中没有这种作用可能表明在这种疾病状态下丧失了正常的氧化还原反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号